Prehospital Point-of-Care Hs-Troponin I for Rule-Out of Acute Myocardial Infarction in Patients Without ST-Segment Elevation

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorCentral Denmark Region

About this trial

People who call emergency medical services (EMS) with chest pain or other possible heart-related symptoms are often taken to hospital for further testing. However, only a small proportion of these patients are ultimately diagnosed with a serious heart condition such as a heart attack. This means that many patients undergo hospital transport and evaluation even though their risk is low.

In hospitals, a blood test called high-sensitivity cardiac troponin is commonly used to help diagnose or rule out heart attacks. It is not yet well established whether this type of test can be used safely and effectively earlier, in the prehospital setting.

This study will investigate whether it is feasible to measure high-sensitivity troponin in the ambulance and how well the test can identify patients at low risk of serious heart conditions. A small blood sample will be taken as part of routine care and analyzed using a portable device. The test result will not be used to guide treatment or decisions during the study.

The study will assess how well the test predicts heart-related events within 30 days and how practical it is to perform the test in real-life emergency settings. The results may help guide future research on how to improve early assessment and decision-making for patients with suspected heart disease.

Eligibility criteria

Qualifiers

Age 18 years or older

Assessed by one of the participating EMS units equipped for POCT sampling

Presentation with symptoms suggestive of acute coronary syndrome

Planned transport to hospital for further evaluation

Disqualifiers

ST-segment elevation on prehospital electrocardiogram

Clinical condition requiring immediate life-saving intervention precluding study procedures

Interhospital transport

Prior inclusion in the study within 30 days

Trial design

Treatments tested in this trial

  • Prehospital high-sensitivity cardiac troponin I measurement

Treatment groups

500 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators